Drug Trials News for December 2010

First Effective Non-Opioid Treatment in Two Decades Could be Available Within Two Years

A breakthrough drug containing theobromine, an ingredient naturally present in cocoa and chocolate, is entering the final stages of human clinical trials for the treatment of persistent cough, researchers announced today. The drug is being jointly developed by SEEK, a leading UK privately-owned drug-discovery group, and could be on the market within two years.
20 December, 2010

New Data Suggest a Potential Role for AT9283 in Combination With Lenalidomide and With Docetaxel in the Treatment of Multiple Myeloma and Non-Hodgkin’s Lymphoma

Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, today announced presentations of new data on its combinatorial oncogenic kinase inhibitor AT9283. The presentations will be made during the 52nd American Society of Hematology Meeting, 4-7th December in Orlando.
08 December, 2010

Drug Trials News Archive

First Effective Non-Opioid Treatment in Two Decades Could be Available Within Two Years First Effective Non-Opioid Treatment in Two Decades Could be Available Within Two Years

First Effective Non-Opioid Treatment in Two Decades Could be Available Within Two Years